Back to Search Start Over

Fosun Pharma signs exclusive license agreement with Shanghai Henlius Biotech

Source :
M2 EquityBites (EQB). January 9, 2023
Publication Year :
2023

Abstract

M2 EQUITYBITES-January 9, 2023-Fosun Pharma signs exclusive license agreement with Shanghai Henlius Biotech (C)2023 M2 COMMUNICATIONS http://www.m2.co.uk Fosun Pharma (600196.SH, 02196.HK), a global pharmaceutical and healthcare industry group deep-rooted in [...]

Subjects

Subjects :
Biotechnology
Biotechnology industry -- Licensing agreements
Health care industry -- Licensing agreements
Monoclonal antibodies
Health care industry
Company licensing agreement
Business

Details

Language :
English
Database :
Gale General OneFile
Journal :
M2 EquityBites (EQB)
Publication Type :
News
Accession number :
edsgcl.732656840

Tools

Authors Abstract Subjects Details